Intrinsic Value of S&P & Nasdaq Contact Us

Incyte Corporation INCY NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
82/100
6/7 Pass
SharesGrow Intrinsic Value
$117.61
+20.4%
Analyst Price Target
$108.90
+11.5%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

Incyte Corporation (INCY) has shown strong revenue growth over the past 3 years, expanding from $3.4B to $5.1B (average +15%/yr). Net income reached $1.3B, reflecting exceptional earnings expansion at +1275.3%/yr on average. The net profit margin is 25%, which is exceptional. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 91.5% (high), with a -2.4pp trend over the period. With a $19B market cap and MOAT composite score of 71/100, the company has a strong competitive position.

Criteria proven by this page:

  • GROWTH (90/100, Pass) — proving strong growth momentum
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 33-year history, the company was profitable in 11 of 33 years — a mixed long-term record
  • INCOME (85/100, Pass) — proves strong profitability and pricing power
  • MOAT (71/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 82/100 with 6/7 criteria passed.

82/100
SG Score
View full scorecard →
VALUE
77/100
Price-to-Earnings & upside
→ IV page
~
FUTURE
52/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 yrs profit
EPS $6.41
Proven by this page
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
71/100
Score: 71/100
GM 91.5% (-2.4pp)
Proven by this page
GROWTH
90/100
Rev +15%/yr
NI +1275.3%/yr
Proven by this page
INCOME
85/100
Margin 25%
$5.1B
Proven by this page
Incyte Corporation Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $5.14B$5.14B$4.24B$3.7B$3.39B
Gross Profit $4.74B$4.7B$3.93B$3.44B$3.19B
Gross Margin 92.1%91.5%92.6%93.1%93.9%
Operating Income $1.34B$1.34B$61.37M$620.53M$579.44M
Net Income $1.29B$1.29B$32.62M$597.6M$340.66M
Net Margin 25%25%0.8%16.2%10%
EPS (Diluted) $6.41$6.41$0.15$2.65$1.52
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message